RDNT — RadNet, Inc.

RadNet Inc. Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: Increased by 22.1% year-over-year, reaching record levels despite an estimated $13 million revenue loss due to severe winter weather.
• Adjusted EBITDA: Grew by 36.3%, with a margin improvement of 115 basis points. Adjusted for weather impacts, the margin improved by 52 basis points.
• Cash Position: Ended the quarter with $455 million in cash and a net debt to adjusted EBITDA ratio of slightly under 2.
• Days Sales Outstanding (DSO): Achieved a record low of 29.5 days, indicating improved cash collection efficiency.

2. Strategic Updates and Business Highlights:

• Advanced Imaging Growth: Advanced imaging accounted for 29.3% of procedural volume, up from 26.9% year-over-year, driven by capital investments in advanced imaging equipment.
• Acquisitions: Completed two significant acquisitions in January—Radiology Regional in Florida and Northwest Radiology in Indiana. Integration is progressing well, with both expected to meet or exceed their 2026 revenue targets.
• Digital Health Segment: The Digital Health division's annual recurring revenue (ARR) reached $97 million, reflecting a 95% year-over-year growth. The acquisition of Gleamer SAS is expected to enhance AI capabilities in imaging.
• Joint Ventures: Announced a new partnership with Trinity Health’s Saint Alphonsus Health System, expanding RadNet’s footprint and revenue potential.

3. Forward Guidance and Outlook:

• 2026 Guidance Raised: Full-year guidance for imaging center revenue, adjusted EBITDA, and free cash flow has been increased due to strong performance in Q1 and positive trends continuing into Q2.
• Digital Health Guidance: Reaffirmed guidance for Digital Health revenue between $135 million to $145 million and adjusted EBITDA of $10 million to $12 million.

4. Bad News, Challenges, or Points of Concern:

• Weather Impact: Severe winter weather in January and February negatively affected revenue and EBITDA, highlighting vulnerability to external factors.
• Routine Imaging Performance: Routine imaging volumes were flat, suggesting a potential crowding-out effect from advanced imaging growth. The company anticipates routine imaging growth will be modest, aligning with population growth.
• Integration Risks: While acquisitions are performing well, there is always inherent risk in integrating new operations and ensuring they meet financial expectations.
• Market Pressures: The competitive landscape in healthcare imaging is evolving, with pressures from new technologies and changing reimbursement models.

5. Notable Q&A Insights:

• Volume Growth: Management expressed confidence in the sustainability of advanced imaging growth, attributing it to technological advancements and operational efficiencies.
• Acquisition Contributions: Approximately two-thirds of EBITDA growth is expected to come from same-center performance, with acquisitions contributing less than one-third.
• AI Implementation: AI is projected to be applied to 70% of RadNet's studies by the end of 2026, with ongoing efforts to enhance productivity and reimbursement opportunities.
• Capitated Contracts: There is potential for future capitated contracts with specialty providers, but profitability will depend on the financial viability of such arrangements.

Overall, RadNet's Q1 2026 results reflect strong growth and strategic positioning, particularly in advanced imaging and digital health, despite facing challenges from external factors and routine imaging performance. The company remains optimistic about future growth driven by ongoing investments and operational improvements.